From our friends at American Enterprise Institute (AEI), a vivid illustration of big government's reverse…
CFIF on Twitter CFIF on YouTube
Image of the Day: Big Government's Reverse-Midas Touch

From our friends at American Enterprise Institute (AEI), a vivid illustration of big government's reverse-Midas touch -- notice what all of these things have in common:

. [caption id="" align="alignleft" width="562" caption="Big Government: Midas in Reverse"][/caption]

. .…[more]

September 14, 2018 • 10:02 am

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Jester's CourtroomLegal tales stranger than stranger than fiction: Ridiculous and sometimes funny lawsuits plaguing our courts.
Antibiotics Unearthed to Kill Superbugs Print
By Betsy McCaughey
Wednesday, March 07 2018
Because new cures are years away, it's essential to protect patients today by stopping these deadly germs from entering their bodies.

Top public health authorities descended on Capitol Hill Thursday to sound the alarm about a grim future without antibiotics. These lifesaving drugs are losing their mojo as germs adapt to them. It's a process scientists call antibiotic resistance.

In the United States, two million people a year fall victim to drug-resistant infections, 23,000 die, and the toll "is growing," says Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. Most are hospital patients.

If new antibiotics aren't discovered, then "procedures we take for granted  including chemotherapy, joint replacement surgery, kidney dialysis, organ transplants" and even simple surgeries would be "too risky to undertake," Pew Charitable Trusts' Allan Coukell warned Congress. A frightening forecast. But don't fear an antibiotic apocalypse yet.

Researchers at Rockefeller University in New York City have just come upon a new class of antibiotics and developed a speedier, less costly way to replenish the antibiotic pipeline in the future. The blockbuster findings are proving the prophets of doom wrong.

Since penicillin was discovered in a moldy petri dish nearly a century ago, most antibiotics have been found in soil and then reproduced in labs. Conventional wisdom says the supply is nearly exhausted. But Sean Brady and his Rockefeller colleagues insist the earth holds many more. "Our idea is, there's this reservoir of antibiotics out in the environment we haven't accessed yet" just waiting to be tapped.

Brady's group set up a project, "Drugs from Dirt," to solicit soil samples, and began poring over them to find new antibiotics. He used a process genetic screening that is far faster and more effective than growing samples in a petri dish.

The results? Malacidin  Latin for killing bad guys  an entirely new category of antibiotics sitting in soil. It's already proven to cure MRSA (methicillin-resistant Staphyloccus aureus) skin infections on lab rats. That said, it will be at least a few years before the drug makes it to the pharmacy. "The malacidin discovery is very exciting," says Paul Auwaerter, a Johns Hopkins scientist, but "it is a long way to a safe effective drug approved by the FDA."

Same deal for another new antibiotic  unearthed recently  teixobactin. In addition, these new antibiotics only treat one of the two families of bacteria  called gram-positive, like Staph. Other drugs in the pipeline will target the other category of bacteria, gram-negatives such as Klebsiella and Acinetobacter. Though they're not household names, they kill by invading a hospital patient's bloodstream or bodily organs, or causing pneumonia.

Because new cures are years away, it's essential to protect patients today by stopping these deadly germs from entering their bodies. Hospitals are "breeding grounds" for superbugs, explains Fauci.

The bacteria lurk on doorknobs, bedrails and other unclean surfaces, morphing constantly to become resistant to antibiotics. When a patient is admitted  wham!  the bad germs attack, invading a surgical incision or climbing in through a breathing device or IV to cause a drug-resistant infection.

Doctors scramble to find a drug to save the patient. But once the germ has invaded the body, it's often too late.

When the drug-resistant germ Klebsiella struck Israeli hospital patients in 2006, the country stopped its spread within a year. How? Testing all patients, isolating those who had it, and even barring nurses treating these patients from having contact with anyone else. Most U.S. hospitals do none of this.

The same germ invaded New York City in 1999. Hospitals kept mum. Public health authorities failed to act. Now it's in all 50 states. What's to blame? Inadequate cleaning, lax medical procedures and a failure to isolate patients carrying the germ. Studies show the germ frequently contaminates hospital rooms and is picked up on the gloves worn by doctors and nurses.

Thrilling new antibiotics are on the way. Scientific innovation will likely prove the naysayers wrong. But tomorrow's cures won't save today's patients. Hospitals  the frontlines in this battle  have to do their part, too. That means cleaning up.


Betsy McCaughey is chairman of the Committee to Reduce Infection Deaths. 
COPYRIGHT 2018 CREATORS.COM

Question of the Week   
Which one of the following is considered to be the country’s first commuter suburb?
More Questions
Quote of the Day   
 
"If Franz Kafka had written about confirmation hearings, he couldn't have come up with a better scenario than the one now unfolding in the US Senate.Brett Kavanaugh, who the day before yesterday was an unimpeachable pillar of the legal establishment, stands accused of a heinous offense that it is almost impossible to definitively rebut.Even if he is completely innocent of the charge that he sexually…[more]
 
 
—Rich Lowry, National Review Editor and Syndicated Columnist
— Rich Lowry, National Review Editor and Syndicated Columnist
 
Liberty Poll   

Which one of the following U.S. Senators do you believe behaved most dishonorably during the Senate Judiciary Committee hearings on the confirmation of Judge Brett Kavanaugh to the Supreme Court?